Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For XY6.DE
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -5.19 1.67 1.76
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 10.46 3.97 3.60
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.41 42.15 41.97
Cash -6.95 3.91 4.21
Capex 21.18 -0.31 -0.39
Free Cash Flow -95.84 0.06 1.49
Revenue -3.89 8.40 8.74
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 3.63 0.37 0.36
Operating Margin 3.19 0.10 0.10
ROA -41.80 < 0.005 0.02
ROE -42.64 0.02 0.03
ROIC -39.02 0.01 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of XY6.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of XY6.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of XY6.DE is permitted for members.